BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449-1472. [PMID: 21705456 DOI: 10.1136/gut.2010.228254] [Cited by in Crossref: 359] [Cited by in F6Publishing: 311] [Article Influence: 32.6] [Reference Citation Analysis]
Number Citing Articles
1 Donlon NE, Sheppard A, Davern M, O'Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J, Nevins Selvadurai P, Bhardwaj A, Foley EK, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, O'Sullivan J, Dunne MR. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines. Cancers (Basel) 2020;12:E3356. [PMID: 33202734 DOI: 10.3390/cancers12113356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Graham D, Lipman G, Sehgal V, Lovat LB. Monitoring the premalignant potential of Barrett's oesophagus'. Frontline Gastroenterol 2016;7:316-22. [PMID: 27761232 DOI: 10.1136/flgastro-2016-100712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
3 Shao M, Li W. Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy. PeerJ 2019;7:e6668. [PMID: 30956903 DOI: 10.7717/peerj.6668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Noble F, Lloyd MA, Turkington R, Griffiths E, O'Donovan M, O'Neill JR, Mercer S, Parsons SL, Fitzgerald RC, Underwood TJ; OCCAMS consortium. Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. Br J Surg 2017;104:1816-28. [PMID: 28944954 DOI: 10.1002/bjs.10627] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
5 Patel N, Foley KG, Powell AG, Wheat JR, Chan D, Fielding P, Roberts SA, Lewis WG. Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancer. Eur J Nucl Med Mol Imaging 2019;46:801-9. [PMID: 30116837 DOI: 10.1007/s00259-018-4118-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lagergren J, Mattsson F, Lagergren P. Weekday of Esophageal Cancer Surgery and Its Relation to Prognosis. Ann Surg 2016;263:1133-7. [PMID: 26565140 DOI: 10.1097/SLA.0000000000001324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
7 Feijó PM, Rodrigues VD, Viana MS, dos Santos MP, Abdelhay E, Viola JP, de Pinho NB, Martucci RB. Effects of ω-3 supplementation on the nutritional status, immune, and inflammatory profiles of gastric cancer patients: A randomized controlled trial. Nutrition 2019;61:125-31. [DOI: 10.1016/j.nut.2018.11.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
8 Antonowicz SS, Lorenzi B, Parker M, Tang CB, Harvey M, Kadirkamanathan SS. Annual computed tomography scans do not improve outcomes following esophagectomy for cancer: a 10-year UK experience. Dis Esophagus 2015;28:365-70. [PMID: 24649807 DOI: 10.1111/dote.12209] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Siosaki MD, Lacerda CF, Bertulucci PA, da Costa Filho JO, de Oliveira AT. Bypass laparoscopic procedure for palliation of esophageal cancer. J Surg Case Rep 2013;2013:rjt017. [PMID: 24964427 DOI: 10.1093/jscr/rjt017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
10 Pucher PH, Allum WH, Bateman AC, Green M, Maynard N, Novelli M, Petty R, Underwood TJ, Gossage J. Consensus recommendations for the standardized histopathological evaluation and reporting after radical oesophago-gastrectomy (HERO consensus). Dis Esophagus 2021:doab033. [PMID: 33969411 DOI: 10.1093/dote/doab033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jang SH, Jung YJ, Kim MG, Kwon SJ. The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study. J Gastric Cancer. 2018;18:48-57. [PMID: 29629220 DOI: 10.5230/jgc.2018.18.e4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
12 Chen MJ, Wu IC, Chen YJ, Wang TE, Chang YF, Yang CL, Huang WC, Chang WK, Sheu BS, Wu MS, Lin JT, Chu CH. Nutrition therapy in esophageal cancer-Consensus statement of the Gastroenterological Society of Taiwan. Dis Esophagus. 2018;31. [PMID: 29860406 DOI: 10.1093/dote/doy016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
13 van Vulpen JK, Siersema PD, van Hillegersberg R, Nieuwenhuijzen GAP, Kouwenhoven EA, Groenendijk RPR, van der Peet DL, Hazebroek EJ, Rosman C, Schippers CCG, Steenhagen E, Peeters PHM, May AM. Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: design of a randomized controlled trial. BMC Cancer 2017;17:552. [PMID: 28821284 DOI: 10.1186/s12885-017-3542-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chang WC, Cheng WC, Cheng BH, Chen L, Ju LJ, Ou YJ, Jeng LB, Yang MD, Hung YC, Ma WL. Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression. Cancer Med 2018;7:1240-52. [PMID: 29493120 DOI: 10.1002/cam4.1295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
15 Horiuchi Y, Hirasawa T, Ishizuka N, Tokai Y, Namikawa K, Yoshimizu S, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J, Tada T. Performance of a computer-aided diagnosis system in diagnosing early gastric cancer using magnifying endoscopy videos with narrow-band imaging (with videos). Gastrointest Endosc 2020; 92: 856-865. e1. [PMID: 32422155 DOI: 10.1016/j.gie.2020.04.079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
16 Abbas MN, Bright T, Price T, Karapetis C, Thompson S, Connell C, Watson D, Barnes M, Bull J, Singhal N, Roy A. Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian population. ANZ J Surg 2021. [PMID: 34617383 DOI: 10.1111/ans.17249] [Reference Citation Analysis]
17 Liu XL, Wang RC, Liu YY, Chen H, Qi C, Hu LW, Yi J, Wang W. Risk prediction nomogram for major morbidity related to primary resection for esophageal squamous cancer. Medicine (Baltimore) 2021;100:e26189. [PMID: 34397790 DOI: 10.1097/MD.0000000000026189] [Reference Citation Analysis]
18 Findlay JM, Antonowicz S, Segaran A, El Kafsi J, Zhang A, Bradley KM, Gillies RS, Maynard ND, Middleton MR. Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery. Eur Radiol 2019;29:2490-8. [PMID: 30643947 DOI: 10.1007/s00330-018-5904-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
19 Woestemeier A, Harms-Effenberger K, Karstens KF, Konczalla L, Ghadban T, Uzunoglu FG, Izbicki JR, Bockhorn M, Pantel K, Reeh M. Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method. Cancers (Basel) 2020;12:E718. [PMID: 32197486 DOI: 10.3390/cancers12030718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
20 Lu Y, Carey S. Translating Evidence-Based Practice Guidelines Into a Summary of Recommendations for the Nutrition Management of Upper Gastrointestinal Cancers. Nutr Clin Pract 2014;29:518-25. [DOI: 10.1177/0884533614532501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
21 Pereira NAM, Laranjo M, Nascimento BFO, Simões JCS, Pina J, Costa BDP, Brites G, Braz J, Seixas de Melo JS, Pineiro M, Botelho MF, Pinho E Melo TMVD. Novel fluorinated ring-fused chlorins as promising PDT agents against melanoma and esophagus cancer. RSC Med Chem 2021;12:615-27. [PMID: 34046633 DOI: 10.1039/d0md00433b] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 van Rossum P, van Lier A, Lips I, Meijer G, Reerink O, van Vulpen M, Lam M, van Hillegersberg R, Ruurda J. Imaging of oesophageal cancer with FDG-PET/CT and MRI. Clinical Radiology 2015;70:81-95. [DOI: 10.1016/j.crad.2014.07.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
23 Aboul-Enein MS, Knight W, Wulaningsih W, Foley DM, Dellaportas D, Zylstra J, Baker CR, Kelly M, Smyth E, Lagergren J, Maisey N, Allum WH, Gossage JA, Cunningham D, Davies AR; Guy's and St Thomas' Oesophago-gastric Research Group. The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma. J Surg Oncol 2021. [PMID: 34403501 DOI: 10.1002/jso.26648] [Reference Citation Analysis]
24 Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D;  ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38-v49. [PMID: 27664260 DOI: 10.1093/annonc/mdw350] [Cited by in Crossref: 609] [Cited by in F6Publishing: 563] [Article Influence: 101.5] [Reference Citation Analysis]
25 Bornschein J, Leja M. The global challenge of a healthy stomach. Best Pract Res Clin Gastroenterol 2014;28:949-51. [PMID: 25439062 DOI: 10.1016/j.bpg.2014.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Ahmad J, Loughrey MB, Donnelly D, Ranaghan L, Shah R, Napolitano G, Kennedy AJ. Prognostic value of added stratification of circumferential resection margin status in oesophageal carcinoma. Histopathology 2013;62:752-63. [DOI: 10.1111/his.12078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
27 Bernards N, Haj Mohammad N, Creemers GJ, Rozema T, Roukema JA, Nieuwenhuijzen GA, van Laarhoven HW, van der Sangen M, Lemmens VE. Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013. Acta Oncol. 2016;55:1161-1167. [PMID: 27174793 DOI: 10.1080/0284186x.2016.1176249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Wang F, Zhu W, Yang R, Xie W, Wang D. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway. Mol Cell Biochem 2019;456:73-83. [PMID: 30635820 DOI: 10.1007/s11010-018-03491-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
29 Konczalla L, Ghadban T, Effenberger KE, Wöstemeier A, Riethdorf S, Uzunoglu FG, Izbicki JR, Pantel K, Bockhorn M, Reeh M. Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer. Ann Surg 2021;273:299-305. [PMID: 31188197 DOI: 10.1097/SLA.0000000000003406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
30 Rodríguez-Camacho E, Pita-Fernández S, Pértega-Díaz S, López-Calviño B, Seoane-Pillado T. Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis. J Epidemiol 2015;25:231-8. [PMID: 25716135 DOI: 10.2188/jea.JE20140118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
31 Davoodvandi A, Shabani Varkani M, Clark CCT, Jafarnejad S. Quercetin as an anticancer agent: Focus on esophageal cancer. J Food Biochem 2020;44:e13374. [PMID: 32686158 DOI: 10.1111/jfbc.13374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
32 Morgagni P, Tringali D, La Barba G, Vittimberga G, Ercolani G. Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol 2016;1:90. [PMID: 28138655 DOI: 10.21037/tgh.2016.11.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Fugo K, Sunaoshi T, Ozaki A, Sugiyama E, Baba A, Fukamizu Y, Kagayama S, Hasegawa R, Shirai Y, Oshima Y, Koike N, Toshimitsu Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion and positron emission tomography/computed tomography of upper gastrointestinal cancers. Abdom Imaging 2015;40:3012-9. [PMID: 26350283 DOI: 10.1007/s00261-015-0545-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
34 Klameth L, Rath B, Hamilton G. In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines. J Cancer 2017;8:1733-43. [PMID: 28819369 DOI: 10.7150/jca.17816] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Sterzing F, Grenacher L, Debus J. Radiotherapy of gastroesophageal junction cancer. Recent Results Cancer Res. 2012;196:187-199. [PMID: 23129375 DOI: 10.1007/978-3-642-31629-6_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Hayes T, Smyth E, Riddell A, Allum W. Staging in Esophageal and Gastric Cancers. Hematology/Oncology Clinics of North America 2017;31:427-40. [DOI: 10.1016/j.hoc.2017.02.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
37 Chan CM, Lai KKY, Ng EKO, Kiang MN, Kwok TWH, Wang HK, Chan KW, Law TT, Tong DK, Chan KT, Lee NP, Law S. Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients. Oncol Lett 2018;15:3273-80. [PMID: 29435069 DOI: 10.3892/ol.2017.7698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
38 Foley K, Franklin J, Jones C, Coles B, Roberts S, Underwood T, Crosby T. The impact of endoscopic ultrasound on the management and outcome of patients with oesophageal cancer: an update of a systematic review. Clinical Radiology 2022. [DOI: 10.1016/j.crad.2022.02.001] [Reference Citation Analysis]
39 van der Schaaf M, Johar A, Wijnhoven B, Lagergren P, Lagergren J. Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst 2015;107:djv043. [PMID: 25748792 DOI: 10.1093/jnci/djv043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
40 Valero M, Robles-Medranda C. Endoscopic ultrasound in oncology: An update of clinical applications in the gastrointestinal tract. World J Gastrointest Endosc 2017; 9(6): 243-254 [PMID: 28690767 DOI: 10.4253/wjge.v9.i6.243] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
41 Ashrafi D, Memon B, Memon MA. Management of oesophageal intramucosal carcinoma. BMJ Case Rep 2018;2018:bcr-2018-224893. [PMID: 30217797 DOI: 10.1136/bcr-2018-224893] [Reference Citation Analysis]
42 Bunting DM, Lai WW, Berrisford RG, Wheatley TJ, Drake B, Sanders G. Positron emission tomography-computed tomography in oesophageal cancer staging: a tailored approach. World J Surg 2015;39:1000-7. [PMID: 25446482 DOI: 10.1007/s00268-014-2892-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
43 Park JH, Woodley N, Mcmillan DC, Glen P. Palliative stenting for oesophagogastric cancer: tumour and host factors and prognosis. BMJ Support Palliat Care 2019;9:332-9. [DOI: 10.1136/bmjspcare-2017-001490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Wu L, Wang C, Tan X, Cheng Z, Zhao K, Yan L, Liang Y, Liu Z, Liang C. Radiomics approach for preoperative identification of stages I-II and III-IV of esophageal cancer. Chin J Cancer Res. 2018;30:396-405. [PMID: 30210219 DOI: 10.21147/j.issn.1000-9604.2018.04.02] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
45 Uedo N, Gotoda T, Yoshinaga S, Tanuma T, Morita Y, Doyama H, Aso A, Hirasawa T, Yano T, Uchita N, Ho S, Hsieh P. Differences in routine esophagogastroduodenoscopy between Japanese and international facilities: A questionnaire survey: Routine EGD in Japan and overseas. Digestive Endoscopy 2016;28:16-24. [DOI: 10.1111/den.12629] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
46 Pucher PH, Rahman SA, Walker RC, Grace BL, Bateman A, Iveson T, Jackson A, Rees C, Byrne JP, Kelly JJ, Noble F, Underwood TJ. Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis. Eur J Surg Oncol 2020;46:2248-56. [PMID: 32694054 DOI: 10.1016/j.ejso.2020.06.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Saito T, Tanaka K, Ebihara Y, Kurashima Y, Murakami S, Shichinohe T, Hirano S. Novel prognostic score of postoperative complications after transthoracic minimally invasive esophagectomy for esophageal cancer: a retrospective cohort study of 90 consecutive patients. Esophagus 2019;16:155-61. [PMID: 30178429 DOI: 10.1007/s10388-018-0645-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
48 Powell AGMT, Karran A, Blake P, Christian A, Roberts SA, Lewis WG. Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy. BJS Open 2020;4:593-600. [PMID: 32374504 DOI: 10.1002/bjs5.50287] [Reference Citation Analysis]
49 Lv B, Song C, Wu L, Zhang Q, Hou D, Chen P, Yu S, Wang Z, Chu Y, Zhang J, Yang D, Liu J. Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer. Oncotarget 2015;6:9794-806. [PMID: 25909166 DOI: 10.18632/oncotarget.3400] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
50 Velikova G, Absolom K, Hewison J, Holch P, Warrington L, Avery K, Richards H, Blazeby J, Dawkins B, Hulme C, Carter R, Glidewell L, Henry A, Franks K, Hall G, Davidson S, Henry K, Morris C, Conner M, Mcparland L, Walker K, Hudson E, Brown J. Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs. Programme Grants Appl Res 2022;10:1-110. [DOI: 10.3310/fdde8516] [Reference Citation Analysis]
51 Noble F, Nolan L, Bateman AC, Byrne JP, Kelly JJ, Bailey IS, Sharland DM, Rees CN, Iveson TJ, Underwood TJ, Bateman AR. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World J Gastroenterol 2013; 19(48): 9282-9293 [PMID: 24409055 DOI: 10.3748/wjg.v19.i48.9282] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
52 Findlay JM, Middleton MR, Tomlinson I. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Ann Oncol. 2015;26:624-644. [PMID: 25214541 DOI: 10.1093/annonc/mdu449] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
53 Signal V, Gurney J, Inns S, Mcleod M, Sika-paotonu D, Sowerbutts S, Teng A, Sarfati D. Helicobacter pylori , stomach cancer and its prevention in New Zealand. Journal of the Royal Society of New Zealand 2020;50:397-417. [DOI: 10.1080/03036758.2019.1650081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Blencowe NS, Whistance RN, Strong S, Hotton EJ, Ganesh S, Roach H, Callaway M, Blazeby JM. Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer. Br J Cancer. 2013;109:1445-1450. [PMID: 23963146 DOI: 10.1038/bjc.2013.478] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
55 Lahner E, Esposito G, Annibale B. Pernicious Anemia: Time to Justify Endoscopic Monitoring? Clinical Gastroenterology and Hepatology 2016;14:322. [DOI: 10.1016/j.cgh.2015.07.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Chen QY, Zhong Q, Zhou JF, Qiu XT, Dang XY, Cai LS, Su GQ, Xu DB, Lin GT, Guo KQ, Liu ZY, Chen QX, Li P, Li TW, Xie JW, Lin SM, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Zheng CH, Lin W, He QL, Huang CM. Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi-institutional study. Cancer Sci 2020;111:502-12. [PMID: 31710406 DOI: 10.1111/cas.14231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
57 Lohneis P, Rohmann J, Gebauer F, Hieggelke L, Bruns C, Schröder W, Büttner R, Löser H, Quaas A. International Tumor Budding Consensus Conference criteria determine the prognosis of oesophageal adenocarcinoma with poor response to neoadjuvant treatment. Pathology - Research and Practice 2022;232:153844. [DOI: 10.1016/j.prp.2022.153844] [Reference Citation Analysis]
58 Horiuchi Y, Hirasawa T, Ishizuka N, Tokura J, Ishioka M, Tokai Y, Namikawa K, Yoshimizu S, Ishiyama A, Yoshio T, Fujisaki J. Additive effect of evaluating microsurface and microvascular patterns using magnifying endoscopy with narrow-band imaging in gastric cancer: a post-hoc analysis of a single-center observational study. BMC Gastroenterol 2022;22:125. [PMID: 35296263 DOI: 10.1186/s12876-022-02197-x] [Reference Citation Analysis]
59 Reeh M, Ghadban T, Uzunoglu FG, Nentwich MF, Bockhorn M, Pantel K, Izbicki JR, Vashist YK. Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma. Br J Cancer 2017;117:612-8. [PMID: 28704837 DOI: 10.1038/bjc.2017.219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
60 Hu Y, Yoon SS. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surg Oncol 2021;40:101689. [PMID: 34839198 DOI: 10.1016/j.suronc.2021.101689] [Reference Citation Analysis]
61 Zhang C, Zhang G, Sun N, Zhang Z, Xue L, Zhang Z, Yang H, Luo Y, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Wang L, Che Y, Wang F, Wang S, Gao S, Xue Q, Zhang Y, He J. An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma. Signal Transduct Target Ther 2020;5:182. [PMID: 32883946 DOI: 10.1038/s41392-020-00221-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
62 Signal V, Sarfati D, Cunningham R, Gurney J, Koea J, Ellison-Loschmann L. Indigenous inequities in the presentation and management of stomach cancer in New Zealand: a country with universal health care coverage. Gastric Cancer 2015;18:571-9. [PMID: 25098927 DOI: 10.1007/s10120-014-0410-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
63 Mengardo V, Bencivenga M, Weindelmayer J, Pavarana M, Giacopuzzi S, de Manzoni G. Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives. Updates Surg 2018;70:207-11. [PMID: 29846892 DOI: 10.1007/s13304-018-0549-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
64 O'Neill JR, Pak HS, Pairo-Castineira E, Save V, Paterson-Brown S, Nenutil R, Vojtěšek B, Overton I, Scherl A, Hupp TR. Quantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins. Mol Cell Proteomics 2017;16:1138-50. [PMID: 28336725 DOI: 10.1074/mcp.M116.065078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
65 Totonelli G, Maghsoudlou P, Fishman JM, Orlando G, Ansari T, Sibbons P, Birchall MA, Pierro A, Eaton S, De Coppi P. Esophageal tissue engineering: A new approach for esophageal replacement. World J Gastroenterol 2012; 18(47): 6900-6907 [PMID: 23322987 DOI: 10.3748/wjg.v18.i47.6900] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
66 Serrano M, Kikuste I, Dinis-Ribeiro M. Advanced endoscopic imaging for gastric cancer assessment: new insights with new optics? Best Pract Res Clin Gastroenterol. 2014;28:1079-1091. [PMID: 25439073 DOI: 10.1016/j.bpg.2014.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
67 Hale MD, Gotoda T, Hayden JD, Grabsch HI. Endoscopic biopsies from gastrointestinal carcinomas and their suitability for molecular analysis: a review of the literature and recommendations for clinical practice and research. Histopathology 2015;67:147-57. [DOI: 10.1111/his.12626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
68 Chew T, Bright T, Price TJ, Watson DI, Devitt PG. Follow-Up Practices of Surgeons and Medical Oncologists in Australia and New Zealand Following Resection of Esophagogastric Cancers. Ann Thorac Cardiovasc Surg 2017;23:217-22. [PMID: 28819089 DOI: 10.5761/atcs.oa.17-00049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
69 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
70 Foley KG, Jeffries J, Hannon C, Coles B, Bradley KM, Smyth E. Response rate and diagnostic accuracy of early PET-CT during neo-adjuvant therapies in oesophageal adenocarcinoma: A systematic review and meta-analysis. Int J Clin Pract 2021;75:e13906. [PMID: 33300222 DOI: 10.1111/ijcp.13906] [Reference Citation Analysis]
71 Moorcraft SY, Fontana E, Cunningham D, Peckitt C, Waddell T, Smyth EC, Allum W, Thompson J, Rao S, Watkins D, Starling N, Chau I. Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study. BMC Cancer 2016;16:112. [PMID: 26883815 DOI: 10.1186/s12885-016-2145-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
72 Zanotti D, Baiocchi GL, Coniglio A, Mohammadi B, Ministrini S, Mughal M, Tiberio GAM, Dawas K. Follow-up after surgery for gastric cancer: how to do it. Updates Surg 2018;70:293-9. [DOI: 10.1007/s13304-018-0524-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Nilsson M. Postgastrectomy follow-up in the West: evidence base, guidelines, and daily practice. Gastric Cancer 2017;20:135-40. [PMID: 27718134 DOI: 10.1007/s10120-016-0654-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
74 Meng R, Bright T, Woodman RJ, Watson DI. Hospital volume versus outcome following oesophagectomy for cancer in Australia and New Zealand. ANZ Journal of Surgery 2019;89:683-8. [DOI: 10.1111/ans.15058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
75 Oka A, Ishimura N, Ishihara S. A New Dawn for the Use of Artificial Intelligence in Gastroenterology, Hepatology and Pancreatology. Diagnostics (Basel) 2021;11:1719. [PMID: 34574060 DOI: 10.3390/diagnostics11091719] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 D’ugo D, Biondi A, Tufo A, Baiocchi G, Persiani R. Surveillance After Gastric Resection. In: Strong VE, editor. Gastric Cancer. Cham: Springer International Publishing; 2015. pp. 255-70. [DOI: 10.1007/978-3-319-15826-6_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Li J, Tan Y, Zhang D, Li J, Shen S, Jiang Y, Wu J. Value and necessity of pelvic CT in gastric cancer staging: an observational study. Scand J Gastroenterol 2018;53:1097-9. [PMID: 30270701 DOI: 10.1080/00365521.2018.1498121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Brar S, Law C, McLeod R, Helyer L, Swallow C, Paszat L, Seevaratnam R, Cardoso R, Dixon M, Mahar A. Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg. 2013;217:347-57.e1. [PMID: 23664139 DOI: 10.1016/j.jamcollsurg.2013.01.067] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
79 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
80 Lee CM, Jee YS, Lee JH, Son SY, Ahn SH, Park DJ, Kim HH. Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer. World J Gastroenterol 2014; 20(30): 10518-10524 [PMID: 25132770 DOI: 10.3748/wjg.v20.i30.10518] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
81 Guinan EM, Bennett AE, Doyle SL, O'Neill L, Gannon J, Foley G, Elliott JA, O'Sullivan J, Reynolds JV, Hussey J. Measuring the impact of oesophagectomy on physical functioning and physical activity participation: a prospective study. BMC Cancer 2019;19:682. [PMID: 31299920 DOI: 10.1186/s12885-019-5888-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
82 Zhao P, Yan W, Fu H, Lin Y, Chen KN. Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta-analysis. Thorac Cancer 2018;9:1048-55. [PMID: 29927075 DOI: 10.1111/1759-7714.12787] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
83 Camilo V, Barros R, Celestino R, Castro P, Vieira J, Teixeira MR, Carneiro F, Pinto-de-Sousa J, David L, Almeida R. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. BMC Cancer 2014;14:753. [PMID: 25300947 DOI: 10.1186/1471-2407-14-753] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
84 Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen J, Fu JH, Yang H. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma. Cancer Lett 2016;377:97-104. [PMID: 27130665 DOI: 10.1016/j.canlet.2016.04.034] [Cited by in Crossref: 42] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
85 Bencivenga M, Verlato G, Mengardo V, Weindelmayer J, Allum WH. Do all the European surgeons perform the same D2? The need of D2 audit in Europe. Updates Surg 2018;70:189-95. [PMID: 29869322 DOI: 10.1007/s13304-018-0542-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Nishitani M, Yoshida N, Tsuji S, Masunaga T, Hirai H, Miyajima S, Dejima A, Nakashima T, Wakita S, Takemura K, Minato H, Kaneko S, Doyama H. Optimal number of endoscopic biopsies for diagnosis of early gastric cancer. Endosc Int Open 2019;7:E1683-90. [PMID: 31803818 DOI: 10.1055/a-1007-1730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Keskin S, Yıldız I, Sen F, Aydogan F, Kilic L, Ekenel M, Saglam S, Sakar B, Disci R, Aykan F. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC). Clin Transl Oncol 2013;15:403-8. [PMID: 23054756 DOI: 10.1007/s12094-012-0942-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Aurello P, Petrucciani N, Antolino L, Giulitti D, D'Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: Is it time to tailor it? World J Gastroenterol 2017; 23(19): 3379-3387 [PMID: 28596674 DOI: 10.3748/wjg.v23.i19.3379] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
90 Zhang C, Luo Y, Zhang Z, Zhang Z, Zhang G, Wang F, Che Y, Fang L, Zhang Y, Sun N, He J. Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes. Front Cell Dev Biol 2020;8:580005. [PMID: 33392181 DOI: 10.3389/fcell.2020.580005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Salinas M, Flores E, López-garrigós M, Leiva-salinas C. High frequency of anti-parietal cell antibody (APCA) and intrinsic factor blocking antibody (IFBA) in individuals with severe vitamin B12 deficiency – an observational study in primary care patients. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:424-9. [DOI: 10.1515/cclm-2019-0749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Bauer K, Manzini G, Henne-Bruns D, Buechler P. Perioperative chemotherapy for advanced gastric cancer - results from a tertiary-care hospital in Germany. World J Gastrointest Oncol 2020; 12(5): 559-568 [PMID: 32461787 DOI: 10.4251/wjgo.v12.i5.559] [Reference Citation Analysis]
93 Zhang C, Zhang Z, Zhang G, Xue L, Yang H, Luo Y, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Zhang Z, Wang L, Che Y, Wang S, Wang F, Fang L, Zeng Q, Li J, Gao S, Xue Q, Sun N, He J. A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy. Clin Transl Med 2020;10:e156. [PMID: 32898328 DOI: 10.1002/ctm2.156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
94 Saisana M, Griffin SM, May FE. Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation. Oncotarget 2016;7:54445-62. [PMID: 27437872 DOI: 10.18632/oncotarget.10642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
95 Halpern AL, Mccarter MD. Palliative Management of Gastric and Esophageal Cancer. Surgical Clinics of North America 2019;99:555-69. [DOI: 10.1016/j.suc.2019.02.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
96 Huddy JR, Huddy FMS, Markar SR, Tucker O. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review. Dis Esophagus. 2018;31:1-11. [PMID: 29024949 DOI: 10.1093/dote/dox110] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
97 Findlay L, Yao C, Bennett DH, Byrom R, Davies N. Non-inferiority of minimally invasive oesophagectomy: an 8-year retrospective case series. Surg Endosc. 2017;31:3681-3689. [PMID: 28078465 DOI: 10.1007/s00464-016-5406-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
98 de Manzoni G, Verlato G, Bencivenga M, Marrelli D, Di Leo A, Giacopuzzi S, Cipollari C, Roviello F. Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. Eur J Surg Oncol. 2015;41:534-540. [PMID: 25707350 DOI: 10.1016/j.ejso.2015.01.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
99 Xu J, Cao J, Wang Y, Yao X, Wang Y, He Z, Lv W, Hu J. Novel preoperative nutritional assessment tool and prognostic model for ESCC patients. J Cancer 2019;10:3883-92. [PMID: 31417631 DOI: 10.7150/jca.31286] [Reference Citation Analysis]
100 Huang R, Shen K, He Q, Hu Y, Sun C, Guo C, Pan Y. Metabolic Profiling of Urinary Chiral Amino-Containing Biomarkers for Gastric Cancer Using a Sensitive Chiral Chlorine-Labeled Probe by HPLC-MS/MS. J Proteome Res 2021;20:3952-62. [PMID: 34229439 DOI: 10.1021/acs.jproteome.1c00267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Dassen AE, Dikken JL, van de Velde CJ, Wouters MW, Bosscha K, Lemmens VE. Changes in treatment patterns and their influence on long-term survival in patients with stages I-III gastric cancer in The Netherlands. Int J Cancer. 2013;133:1859-1866. [PMID: 23564267 DOI: 10.1002/ijc.28192] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
102 Bunting D, Bracey T, Fox B, Berrisford R, Wheatley T, Sanders G. Loco-regional staging accuracy in oesophageal cancer—How good are we in the modern era? European Journal of Radiology 2017;97:71-5. [DOI: 10.1016/j.ejrad.2017.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
103 Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma: Recent Developments in Esophageal Adenocarcinoma. CA A Cancer Journal for Clinicians 2013;63:232-48. [DOI: 10.3322/caac.21185] [Cited by in Crossref: 182] [Cited by in F6Publishing: 170] [Article Influence: 20.2] [Reference Citation Analysis]
104 Wang J, Xu R, Li J, Bai Y, Liu T, Jiao S, Dai G, Xu J, Liu Y, Fan N, Shu Y, Ba Y, Ma D, Qin S, Zheng L, Chen W, Shen L. Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer. Gastric Cancer. 2016;19:234-244. [PMID: 25604851 DOI: 10.1007/s10120-015-0457-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
105 Noble F, Kelly JJ, Bailey IS, Byrne JP, Underwood TJ. A prospective comparison of totally minimally invasive versus open Ivor Lewis esophagectomy. Dis Esophagus. 2013;26:263-271. [PMID: 23551569 DOI: 10.1111/j.1442-2050.2012.01356.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
106 Han J, Meng Q, Xi Q, Wang H, Wu G. PFKFB3 was overexpressed in gastric cancer patients and promoted the proliferation and migration of gastric cancer cells. Cancer Biomark 2017;18:249-56. [PMID: 27983531 DOI: 10.3233/CBM-160143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
107 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer†: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Radiotherapy and Oncology 2014;110:189-94. [DOI: 10.1016/j.radonc.2013.09.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
108 Chan DS, Fielding P, Roberts SA, Reid TD, Ellis-Owen R, Lewis WG. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer. Clin Radiol. 2013;68:352-357. [PMID: 22981727 DOI: 10.1016/j.crad.2012.08.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
109 Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P, Van Cutsem E, van de Velde C, Cervantes A. Unmet needs and challenges in gastric cancer: the way forward. Cancer Treat Rev. 2014;40:692-700. [PMID: 24656602 DOI: 10.1016/j.ctrv.2014.03.002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 14.6] [Reference Citation Analysis]
110 Li X, Francies HE, Secrier M, Perner J, Miremadi A, Galeano-Dalmau N, Barendt WJ, Letchford L, Leyden GM, Goffin EK, Barthorpe A, Lightfoot H, Chen E, Gilbert J, Noorani A, Devonshire G, Bower L, Grantham A, MacRae S, Grehan N, Wedge DC, Fitzgerald RC, Garnett MJ. Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics. Nat Commun 2018;9:2983. [PMID: 30061675 DOI: 10.1038/s41467-018-05190-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 22.0] [Reference Citation Analysis]
111 Nunes G, Fonseca J, Barata AT, Dinis-Ribeiro M, Pimentel-Nunes P. Nutritional Support of Cancer Patients without Oral Feeding: How to Select the Most Effective Technique? GE Port J Gastroenterol 2020;27:172-84. [PMID: 32509923 DOI: 10.1159/000502981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
112 Foley K, Findlay J, Goh V. Novel imaging techniques in staging oesophageal cancer. Best Practice & Research Clinical Gastroenterology 2018;36-37:17-25. [DOI: 10.1016/j.bpg.2018.11.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
113 Visser E, van Rossum PSN, Ruurda JP, van Hillegersberg R. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands. Ann Surg 2017;266:863-9. [PMID: 28742691 DOI: 10.1097/SLA.0000000000002389] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
114 Wen J, Yang H, Liu MZ, Luo KJ, Liu H, Hu Y, Zhang X, Lai RC, Lin T, Wang HY. Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy. Ann Oncol. 2014;25:1769-1774. [PMID: 24907633 DOI: 10.1093/annonc/mdu201] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
115 Torrance AD, Almond LM, Fry J, Wadley MS, Lyburn ID. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer? Surgeon. 2015;13:19-33. [PMID: 24206935 DOI: 10.1016/j.surge.2013.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
116 Fernandes E, Sores J, Cotton S, Peixoto A, Ferreira D, Freitas R, Reis CA, Santos LL, Ferreira JA. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology. Theranostics 2020;10:4903-28. [PMID: 32308758 DOI: 10.7150/thno.42480] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
117 Wong CS, Aly EH. The effects of enteral immunonutrition in upper gastrointestinal surgery: A systematic review and meta-analysis. International Journal of Surgery 2016;29:137-50. [DOI: 10.1016/j.ijsu.2016.03.043] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
118 Alexandre L, Clark AB, Walton S, Lewis MP, Kumar B, Cheong EC, Warren H, Kadirkamanathan SS, Parsons SL, Dresner SM, Sims E, Jones M, Hammond M, Flather M, Loke YK, Swart AM, Hart AR. Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT-ROC feasibility study. BJS Open 2020;4:59-70. [PMID: 32011825 DOI: 10.1002/bjs5.50239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
119 Morgan E, Soerjomataram I, Gavin AT, Rutherford MJ, Gatenby P, Bardot A, Ferlay J, Bucher O, De P, Engholm G, Jackson C, Kozie S, Little A, Møller B, Shack L, Tervonen H, Thursfield V, Vernon S, Walsh PM, Woods RR, Finley C, Merrett N, O'Connell DL, Reynolds JV, Bray F, Arnold M. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut 2021;70:234-42. [PMID: 32554620 DOI: 10.1136/gutjnl-2020-321089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
120 Miller JA, Groman A, Yendamuri S, Hennon M. Radiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer. J Surg Res 2019;236:259-65. [PMID: 30694764 DOI: 10.1016/j.jss.2018.11.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
121 Halliday LJ, Markar SR, Doran SLF, Moorthy K. Enhanced recovery protocols after oesophagectomy. J Thorac Dis 2017;9:S781-4. [PMID: 28815074 DOI: 10.21037/jtd.2017.07.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
122 Alkhaffaf B, Glenny AM, Blazeby JM, Williamson P, Bruce IA. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study). Trials 2017;18:370. [PMID: 28793921 DOI: 10.1186/s13063-017-2100-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
123 Horiuchi Y, Tokai Y, Yamamoto N, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T, Fujisaki J. Additive Effect of Magnifying Endoscopy with Narrow-Band Imaging for Diagnosing Mixed-Type Early Gastric Cancers. Dig Dis Sci. 2020;65:591-599. [PMID: 31367881 DOI: 10.1007/s10620-019-05762-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
124 Liang TJ, Liu SI, Chen YC, Chang PM, Huang WC, Chang HT, Chen IS. Analysis of gallstone disease after gastric cancer surgery. Gastric Cancer 2017;20:895-903. [PMID: 28154944 DOI: 10.1007/s10120-017-0698-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
125 Li Q, Zhu S, Liu S, Zhang G, Li X. Limited Lymph Node Resection Does Not Decrease Postoperative Mortality After Esophagectomy in Octogenarians With Thoracic Esophageal Cancer. J Surg Res 2021;259:538-45. [PMID: 33162102 DOI: 10.1016/j.jss.2020.10.006] [Reference Citation Analysis]
126 Foley K, Morgan C, Roberts S, Crosby T. Impact of Positron Emission Tomography and Endoscopic Ultrasound Length of Disease Difference on Treatment Planning in Patients with Oesophageal Cancer. Clinical Oncology 2017;29:760-6. [DOI: 10.1016/j.clon.2017.07.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
127 Ren DF, Zheng FC, Zhao JH, Shen GS, Ahmad R, Zhang SS, Zhang Y, Kan J, Dong L, Wang ZY, Zhao FX, Zhao JD. Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study. World J Clin Cases 2018; 6(10): 373-383 [PMID: 30283800 DOI: 10.12998/wjcc.v6.i10.373] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
128 Okada N, Fujii S, Fujita T, Kanamori J, Kojima T, Hayashi R, Daiko H. The prognostic significance of the positive circumferential resection margin in pathologic T3 squamous cell carcinoma of the esophagus with or without neoadjuvant chemotherapy. Surgery 2016;159:441-50. [DOI: 10.1016/j.surg.2015.06.044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
129 Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol 2019;30:584-98. [PMID: 30541724 DOI: 10.5152/tjg.2018.18737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Kwack WG, Ho WJ, Kim JH, Lee JH, Kim EJ, Kang HW, Lee JK. Understanding the diagnostic yield of current endoscopic biopsy for gastric neoplasm: A prospective single-center analysis based on tumor characteristics stratified by biopsy number and site. Medicine (Baltimore) 2016;95:e4196. [PMID: 27472689 DOI: 10.1097/MD.0000000000004196] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
131 Pan B, Zhang W, Chen W, Zheng J, Yang X, Sun J, Sun X, Chen X, Shen X. Establishment of the Radiologic Tumor Invasion Index Based on Radiomics Splenic Features and Clinical Factors to Predict Serous Invasion of Gastric Cancer. Front Oncol 2021;11:682456. [PMID: 34434892 DOI: 10.3389/fonc.2021.682456] [Reference Citation Analysis]
132 Amdal CD, Jacobsen A, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K. Improved treatment decisions in patients with esophageal cancer. Acta Oncologica 2017;56:1286-94. [DOI: 10.1080/0284186x.2017.1346379] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
133 Qin J, Zhu HD, Guo JH, Ni CF, Wu P, Xu H, Mao AW, Lu J, Su C, Teng GJ. Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis. Dis Esophagus 2019;32:doz012. [PMID: 30888392 DOI: 10.1093/dote/doz012] [Reference Citation Analysis]
134 Carabotti M, Lahner E, Esposito G, Sacchi MC, Severi C, Annibale B. Upper gastrointestinal symptoms in autoimmune gastritis: A cross-sectional study. Medicine (Baltimore) 2017;96:e5784. [PMID: 28072728 DOI: 10.1097/MD.0000000000005784] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 5.6] [Reference Citation Analysis]
135 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
136 Zhang GT, Song YC, Zhang XD. Hand-assisted laparoscopic total gastrectomy with regional lymph node dissection for advanced gastric cancer. Surg Laparosc Endosc Percutan Tech. 2014;24:e78-e84. [PMID: 24710226 DOI: 10.1097/sle.0b013e31828fa6fd] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
137 Walker RC, Underwood TJ. Molecular pathways in the development and treatment of oesophageal cancer. Best Practice & Research Clinical Gastroenterology 2018;36-37:9-15. [DOI: 10.1016/j.bpg.2018.11.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
138 Wen J, Luo K, Liu H, Liu S, Lin G, Hu Y, Zhang X, Wang G, Chen Y, Chen Z, Li Y, Lin T, Xie X, Liu M, Wang H, Yang H, Fu J. MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy. Ann Surg 2016;263:942-8. [PMID: 26445467 DOI: 10.1097/SLA.0000000000001489] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
139 Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. The extent of lymphadenectomy in esophageal resection for cancer should be standardized. J Thorac Dis 2017;9:S713-23. [PMID: 28815067 DOI: 10.21037/jtd.2017.07.42] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
140 Dong W, Liu Y, Zhu W, Mou Q, Wang J, Hu Y. Simulation of Swanson's literature-based discovery: anandamide treatment inhibits growth of gastric cancer cells in vitro and in silico. PLoS One 2014;9:e100436. [PMID: 24949851 DOI: 10.1371/journal.pone.0100436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
141 Saunders JH, Onion D, Collier P, Dorrington MS, Argent RH, Clarke PA, Reece-Smith AM, Parsons SL, Grabowska AM. Individual patient oesophageal cancer 3D models for tailored treatment. Oncotarget 2017;8:24224-36. [PMID: 27736801 DOI: 10.18632/oncotarget.12500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
142 Runkel M, Verst R, Spiegelberg J, Fichtner-Feigl S, Hoeppner J, Glatz T. Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival. BMC Surg 2021;21:35. [PMID: 33435947 DOI: 10.1186/s12893-020-01035-9] [Reference Citation Analysis]
143 Thomson IG, Gotley DC, Barbour AP, Martin I, Jayasuria N, Thomas J, Smithers BM. Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes. Gastric Cancer. 2014;17:152-160. [PMID: 23474836 DOI: 10.1007/s10120-013-0240-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
144 Kamarajah SK, Boyle C, Bundred JR, Tan BH. Critical appraisal of gastric conduit ischaemic conditioning (GIC) prior to oesophagectomy: A systematic review and meta-analysis. Int J Surg 2020;77:77-82. [PMID: 32198097 DOI: 10.1016/j.ijsu.2020.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 O'Neill JR, Kennedy ED, Save V, Langdale-Brown B, Wall L, Skipworth RJE, Paterson-Brown S. Patients unfit for neoadjuvant therapy may still undergo resection of locally advanced esophageal or esophagogastric junctional cancer with acceptable oncological results. Int J Surg Oncol (N Y) 2017;2:e09. [PMID: 29177210 DOI: 10.1097/IJ9.0000000000000009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
146 Laquente B, Calsina-Berna A, Carmona-Bayonas A, Jiménez-Fonseca P, Peiró I, Carrato A. Supportive care in pancreatic ductal adenocarcinoma. Clin Transl Oncol 2017;19:1293-302. [PMID: 28612201 DOI: 10.1007/s12094-017-1682-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
147 Peppelenbosch MP, Spaander MCW, Bruno MJ. Glutathione peroxidase 7 prevents cancer in the oesophagus. Gut 2014;63:537-8. [DOI: 10.1136/gutjnl-2013-304906] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
148 Cao J, Yuan P, Wang L, Wang Y, Ma H, Yuan X, Lv W, Hu J. Clinical Nomogram for Predicting Survival of Esophageal Cancer Patients after Esophagectomy. Sci Rep 2016;6:26684. [PMID: 27215834 DOI: 10.1038/srep26684] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
149 Kanesaka T, Lee TC, Uedo N, Lin KP, Chen HZ, Lee JY, Wang HP, Chang HT. Computer-aided diagnosis for identifying and delineating early gastric cancers in magnifying narrow-band imaging. Gastrointest Endosc. 2018;87:1339-1344. [PMID: 29225083 DOI: 10.1016/j.gie.2017.11.029] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 14.2] [Reference Citation Analysis]
150 Merchant SJ, Kong W, Gyawali B, Hanna TP, Chung W, Nanji S, Patel SV, Booth CM. First-Line Palliative Chemotherapy for Esophageal and Gastric Cancer: Practice Patterns and Outcomes in the General Population. JCO Oncol Pract 2021;:OP2000397. [PMID: 33449833 DOI: 10.1200/OP.20.00397] [Reference Citation Analysis]
151 Miller KR, Bozeman MC. Nutrition therapy issues in esophageal cancer. Curr Gastroenterol Rep 2012;14:356-66. [PMID: 22730015 DOI: 10.1007/s11894-012-0272-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
152 Wan JF, Yang LF, Shen YZ, Jia HX, Zhu J, Li GC, Zhang Z. Sex, Race, and Age Disparities in the Improvement of Survival for Gastrointestinal Cancer over Time. Sci Rep 2016;6:29655. [PMID: 27406065 DOI: 10.1038/srep29655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
153 Bauer K, Schroeder M, Porzsolt F, Henne-Bruns D. Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences. J Gastric Cancer. 2015;15:10-18. [PMID: 25861518 DOI: 10.5230/jgc.2015.15.1.10] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
154 Giacopuzzi S, Bencivenga M, Cipollari C, Weindelmayer J, de Manzoni G. Lymphadenectomy: how to do it? Transl Gastroenterol Hepatol 2017;2:28. [PMID: 28447063 DOI: 10.21037/tgh.2017.03.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
155 Hiller JG, Hacking MB, Link EK, Wessels KL, Riedel BJ. Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery: Epidurals and gastro-oesophageal cancer. Acta Anaesthesiol Scand 2014;58:281-90. [DOI: 10.1111/aas.12255] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
156 Pournaras DJ, le Roux CW. Type 2 diabetes: multimodal treatment of a complex disease. The Lancet 2015;386:936-7. [DOI: 10.1016/s0140-6736(15)00132-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
157 Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: A review. World J Gastrointest Oncol 2018; 10(11): 398-409 [PMID: 30487951 DOI: 10.4251/wjgo.v10.i11.398] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
158 Rice SR, Chuong M, Koroulakis A, Siddiqui OM, Sharma AM, Simone CB 2nd, Molitoris JK, Kaiser A. The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal Tumors. PET Clin 2020;15:77-87. [PMID: 31735304 DOI: 10.1016/j.cpet.2019.08.004] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
159 Huang W, Han Y, Xu J, Zhu W, Li Z. Red and processed meat intake and risk of esophageal adenocarcinoma: a meta-analysis of observational studies. Cancer Causes Control 2013;24:193-201. [PMID: 23179661 DOI: 10.1007/s10552-012-0105-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
160 Xia W, Liu S, Mao Q, Chen B, Ma W, Dong G, Xu L, Jiang F. Effect of lymph node examined count on accurate staging and survival of resected esophageal cancer. Thorac Cancer 2019;10:1149-57. [PMID: 30957414 DOI: 10.1111/1759-7714.13056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
161 Low DE, Bodnar A. Update on clinical impact, documentation, and management of complications associated with esophagectomy. Thorac Surg Clin. 2013;23:535-550. [PMID: 24199703 DOI: 10.1016/j.thorsurg.2013.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
162 Charruf AZ, Ramos MFKP, Pereira MA, Dias AR, de Castria TB, Zilberstein B, Cecconelo I, Ribeiro U. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control study. J Surg Oncol 2020;121:833-9. [PMID: 31943232 DOI: 10.1002/jso.25839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
163 Groene O, Crosby T, Hardwick RH, Riley S, Greenaway K, Cromwell D. A population-based observational study on the factors associated with the completion of palliative chemotherapy among patients with oesophagogastric cancer. BMJ Open 2015;5:e006724. [PMID: 25740023 DOI: 10.1136/bmjopen-2014-006724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
164 Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J;  British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7-42. [PMID: 24165758 DOI: 10.1136/gutjnl-2013-305372] [Cited by in Crossref: 733] [Cited by in F6Publishing: 584] [Article Influence: 81.4] [Reference Citation Analysis]
165 Jin SB, Tian ZB, Ding XL, Guo YJ, Mao T, Yu YN, Wang KX, Jing X. The Impact of Preoperative Sarcopenia on Survival Prognosis in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:619592. [PMID: 34249675 DOI: 10.3389/fonc.2021.619592] [Reference Citation Analysis]
166 Markar SR, Mackenzie H, Mikhail S, Mughal M, Preston SR, Maynard ND, Faiz O, Hanna GB. Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England. Gastric Cancer. 2017;20:379-386. [PMID: 26939792 DOI: 10.1007/s10120-016-0604-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
167 Yoshikawa T, Rino Y, Yukawa N, Oshima T, Tsuburaya A, Masuda M. Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy. Surg Today. 2014;44:11-21. [PMID: 23508452 DOI: 10.1007/s00595-013-0529-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
168 Brenkman HJ, Parry K, Noble F, van Hillegersberg R, Sharland D, Goense L, Kelly J, Byrne JP, Underwood TJ, Ruurda JP. Hiatal Hernia After Esophagectomy for Cancer. The Annals of Thoracic Surgery 2017;103:1055-62. [DOI: 10.1016/j.athoracsur.2017.01.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
169 Harris C, Ostwal V, Vallathol DH, Dusane R, Mandavkar S, Patkar S, Ramaswamy A, Shrikhande SV. Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers. South Asian J Cancer 2019;8:166-7. [PMID: 31489289 DOI: 10.4103/sajc.sajc_182_18] [Reference Citation Analysis]
170 Sinha S, Varagunam M, Park M, Maynard N, Trudgill N, Crosby T, Cromwell D. Brachytherapy in the Palliation of Oesophageal Cancer: Effective but Impractical? Clinical Oncology 2019;31:e87-93. [DOI: 10.1016/j.clon.2019.03.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
171 Chen XZ, Zhang WH, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population. Tumour Biol. 2014;35:9015-9022. [PMID: 24906604 DOI: 10.1007/s13277-014-1986-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
172 Chadwick G, Groene O, Riley S, Hardwick R, Crosby T, Hoare J, Hanna GB, Greenaway K, Cromwell DA. Gastric Cancers Missed During Endoscopy in England. Clinical Gastroenterology and Hepatology 2015;13:1264-1270.e1. [DOI: 10.1016/j.cgh.2015.01.025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
173 Wang FH, Shen L, Li J, Zhou ZW, Liang H, Zhang XT, Tang L, Xin Y, Jin J, Zhang YJ, Yuan XL, Liu TS, Li GX, Wu Q, Xu HM, Ji JF, Li YF, Wang X, Yu S, Liu H, Guan WL, Xu RH. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond). 2019;39:10. [PMID: 30885279 DOI: 10.1186/s40880-019-0349-9] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 41.0] [Reference Citation Analysis]
174 Sun F, Chen T, Han J, Ye P, Hu J. Staging accuracy of endoscopic ultrasound for esophageal cancer after neoadjuvant chemotherapy: a meta-analysis and systematic review: Staging accuracy of EUS. Dis Esophagus 2015;28:757-71. [DOI: 10.1111/dote.12274] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
175 Allum WH, Smyth EC, Blazeby JM, Grabsch HI, Griffin SM, Rowley S, Cafferty FH, Langley RE, Cunningham D. Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction. Br J Surg 2019;106:1204-15. [PMID: 31268180 DOI: 10.1002/bjs.11184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
176 Dixon M, Cardoso R, Tinmouth J, Helyer L, Law C, Swallow C, Paszat L, McLeod R, Seevaratnam R, Mahar A, Coburn NG; Gastric Cancer Processes of Care Expert Panel. What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel. Gastric Cancer 2014;17:377-82. [PMID: 23633230 DOI: 10.1007/s10120-013-0262-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
177 Gurusamy KS, Pallari E, Midya S, Mughal M. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer. Cochrane Database Syst Rev 2016;3:CD011390. [PMID: 27030301 DOI: 10.1002/14651858.CD011390.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
178 Chan D, Reid T, White C, Willicombe A, Blackshaw G, Clark G, Havard T, Escofet X, Crosby T, Roberts S, Lewis W. Influence of a Regional Centralised Upper Gastrointestinal Cancer Service Model on Patient Safety, Quality of Care and Survival. Clinical Oncology 2013;25:719-25. [DOI: 10.1016/j.clon.2013.08.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
179 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO); European Society of Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO). Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40:584-591. [PMID: 24685156 DOI: 10.1016/j.ejso.2013.09.020] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 12.9] [Reference Citation Analysis]
180 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer 2019;19:1-48. [PMID: 30944757 DOI: 10.5230/jgc.2019.19.e8] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 34.3] [Reference Citation Analysis]
181 Varagunam M, Hardwick R, Riley S, Chadwick G, Cromwell D, Groene O. Changes in volume, clinical practice and outcome after reorganisation of oesophago-gastric cancer care in England: A longitudinal observational study. European Journal of Surgical Oncology 2018;44:524-31. [DOI: 10.1016/j.ejso.2018.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
182 Celli R, Barbieri AL, Colunga M, Sinard J, Gibson JA. Optimal Intraoperative Assessment of Gastric Margins. American Journal of Clinical Pathology 2018;150:353-63. [DOI: 10.1093/ajcp/aqy062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
183 Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R. Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis. Ann Surg 2019;269:261-8. [PMID: 29794846 DOI: 10.1097/SLA.0000000000002824] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 13.3] [Reference Citation Analysis]
184 Fusaroli P, Kypraios D, Caletti G, Eloubeidi MA. Pancreatico-biliary endoscopic ultrasound: A systematic review of the levels of evidence, performance and outcomes. World J Gastroenterol 2012; 18(32): 4243-4256 [PMID: 22969187 DOI: 10.3748/wjg.v18.i32.4243] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
185 Pye H, Butt MA, Funnell L, Reinert HW, Puccio I, Rehman Khan SU, Saouros S, Marklew JS, Stamati I, Qurashi M, Haidry R, Sehgal V, Oukrif D, Gandy M, Whitaker HC, Rodriguez-Justo M, Novelli M, Hamoudi R, Yahioglu G, Deonarain MP, Lovat LB. Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression. Oncotarget 2018;9:22945-59. [PMID: 29796164 DOI: 10.18632/oncotarget.25159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
186 Heinzow HS, Seifert H, Tsepetonidis S, Wolters H, Kucharzik T, Domschke W, Domagk D, Meister T. Endoscopic Ultrasound in Staging Esophageal Cancer After Neoadjuvant Chemotherapy—Results of a Multicenter Cohort Analysis. J Gastrointest Surg 2013;17:1050-7. [DOI: 10.1007/s11605-013-2189-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
187 Chang WC, Huang SF, Lee YM, Lai HC, Cheng BH, Cheng WC, Ho JY, Jeng LB, Ma WL. Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival. Oncotarget 2017;8:692-704. [PMID: 27893427 DOI: 10.18632/oncotarget.13524] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
188 van Rossum PSN, Mohammad NH, Vleggaar FP, van Hillegersberg R. Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends. Nat Rev Gastroenterol Hepatol. 2018;15:235-249. [PMID: 29235549 DOI: 10.1038/nrgastro.2017.162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
189 Park JH, Kim S, Park JW, Ko SJ, Lee S. Feasibility study of structured diagnosis methods for functional dyspepsia in Korean medicine clinics. Integr Med Res 2017;6:443-51. [PMID: 29296572 DOI: 10.1016/j.imr.2017.10.001] [Reference Citation Analysis]
190 Ho VK, Damhuis RA, Hartgrink HH. Adherence to national guidelines for gastric cancer in the Netherlands: a retrospective population-based audit. Int J Cancer 2013;132:1156-61. [PMID: 22777695 DOI: 10.1002/ijc.27718] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
191 Yang L, Shi G, Zhou T, Li Y, Li Y. Quantification of the Iodine Content of Perigastric Adipose Tissue by Dual-Energy CT: A Novel Method for Preoperative Diagnosis of T4-Stage Gastric Cancer. PLoS One. 2015;10:e0136871. [PMID: 26372042 DOI: 10.1371/journal.pone.0136871] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
192 Pucher PH, Coombes A, Evans O, Taylor J, Moore JL, White A, Lagergren J, Baker C, Kelly M, Gossage JA, Dunn J, Zeki S, Byrne BE, Andreyev J, Davies AR; RESTORE study group, Guy’s, St Thomas’ Oesophago-gastric research group. Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery. Support Care Cancer 2022. [PMID: 35275293 DOI: 10.1007/s00520-022-06922-w] [Reference Citation Analysis]
193 Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW, Delgado-Bolton R, Haustermans K, Henning G, Hutter B, Lövey J, Netíková IŠ, Obermannová R, Oberst S, Rostoft S, Saarto T, Seufferlein T, Sheth S, Wynter-Blyth V, Costa A, Naredi P. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 2018;122:179-93. [PMID: 29458786 DOI: 10.1016/j.critrevonc.2017.12.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
194 Xie YL, Tao WH, Yang TX, Qiao JG. Anticancer effect of cucurbitacin B on MKN-45 cells via inhibition of the JAK2/STAT3 signaling pathway. Exp Ther Med 2016;12:2709-15. [PMID: 27698776 DOI: 10.3892/etm.2016.3670] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
195 Ikebe M, Morita M, Yamamoto M, Toh Y. Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management. Gen Thorac Cardiovasc Surg 2016;64:386-94. [DOI: 10.1007/s11748-016-0655-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
196 Stokes SM, Wakeam E, Antonoff MB, Backhus LM, Meguid RA, Odell D, Varghese TK Jr. Optimizing health before elective thoracic surgery: systematic review of modifiable risk factors and opportunities for health services research. J Thorac Dis 2019;11:S537-54. [PMID: 31032072 DOI: 10.21037/jtd.2019.01.06] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
197 Mukherjee P, Lim TC, Chawla A. Imaging of the Esophagus. In: Chawla A, editor. Thoracic Imaging. Singapore: Springer; 2019. pp. 295-324. [DOI: 10.1007/978-981-13-2544-1_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Foley KG, Lavery A, Napier E, Campbell D, Eatock MM, Kennedy RD, Bradley KM, Turkington RC. A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma. Sci Rep 2021;11:13061. [PMID: 34158588 DOI: 10.1038/s41598-021-92545-w] [Reference Citation Analysis]
199 Luo J, Jiang Y, Chen X, Chen Y, Gurung JL, Mou T, Zhao L, Lyu G, Li T, Li G, Yu J. Prognostic value and nomograms of proximal margin distance in gastric cancer with radical distal gastrectomy. Chin J Cancer Res 2020;32:186-96. [PMID: 32410796 DOI: 10.21147/j.issn.1000-9604.2020.02.06] [Reference Citation Analysis]
200 Van Laethem J, Carneiro F, Ducreux M, Messman H, Lordick F, Ilson D, Allum W, Haustermans K, Lepage C, Matysiak-budnik T, Cats A, Schmiegel W, Cervantes A, Van Cutsem E, Rougier P, Seufferlein T. The multidisciplinary management of gastro-oesophageal junction tumours. Digestive and Liver Disease 2016;48:1283-9. [DOI: 10.1016/j.dld.2016.08.112] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
201 Markar SR, Mackenzie H, Askari A, Faiz O, Hanna GB. Effect of Esophageal Cancer Surgeon Volume on Management and Mortality From Emergency Upper Gastrointestinal Conditions: Population-based Cohort Study. Annals of Surgery 2017;266:847-53. [DOI: 10.1097/sla.0000000000002387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
202 Yoshikawa T, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Hasegawa S, Aoyama T, Hayashi T, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study. Ann Surg Oncol. 2014;21 Suppl 3:S385-S389. [PMID: 24595801 DOI: 10.1245/s10434-014-3615-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
203 Totonelli G, Maghsoudlou P, Georgiades F, Garriboli M, Koshy K, Turmaine M, Ashworth M, Sebire NJ, Pierro A, Eaton S, De Coppi P. Detergent enzymatic treatment for the development of a natural acellular matrix for oesophageal regeneration. Pediatr Surg Int 2013;29:87-95. [PMID: 23124129 DOI: 10.1007/s00383-012-3194-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
204 Hategan M, Cook N, Prewett S, Hindmarsh A, Qian W, Gilligan D. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature: Trimodality therapy in esophageal cancer. Dis Esophagus 2015;28:612-8. [DOI: 10.1111/dote.12242] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
205 Kishino T, Oyama T, Funakawa K, Ishii E, Yamazato T, Shibagaki K, Miike T, Tanuma T, Kuwayama Y, Takeuchi M, Kitamura Y. Multicenter prospective study on the histological diagnosis of gastric cancer by narrow band imaging-magnified endoscopy with and without acetic acid. Endosc Int Open. 2019;7:E155-E163. [PMID: 30705947 DOI: 10.1055/a-0806-7275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
206 Hellstadius Y, Malmström M, Lagergren P, Sundbom M, Wikman A. Reflecting a crisis reaction: Narratives from patients with oesophageal cancer about the first 6 months after diagnosis and surgery. Nurs Open 2019;6:1471-80. [PMID: 31660175 DOI: 10.1002/nop2.348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
207 Rutegård M, Lagergren P, Johar A, Rouvelas I, Lagergren J. The prognostic role of coeliac node metastasis after resection for distal oesophageal cancer. Sci Rep 2017;7:43744. [PMID: 28256597 DOI: 10.1038/srep43744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
208 Chadwick G, Riley S, Hardwick RH, Crosby T, Hoare J, Hanna G, Greenaway K, Varagunam M, Cromwell DA, Groene O. Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England. Br J Surg 2016;103:544-52. [PMID: 26865114 DOI: 10.1002/bjs.10116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
209 Howard JM, Johnston C. Patterns of lymphatic drainage and lymph node involvement in esophageal cancer. Abdom Imaging 2013;38:233-43. [PMID: 22711183 DOI: 10.1007/s00261-012-9914-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
210 Zhang S, Khaliq J, Li D, Jiang X, Sun R, Li Y. Robotic total gastrectomy with π-shaped esophagojejunostomy using a linear stapler as a novel technique. World J Surg Oncol 2018;16:238. [PMID: 30577805 DOI: 10.1186/s12957-018-1542-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
211 Tomizawa M, Shinozaki F, Fugo K, Sunaoshi T, Kano D, Tanaka S, Ozaki A, Sugiyama E, Shite M, Haga R, Baba A, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Togawa A, Shirai Y, Ichiki N, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Diffusion-weighted whole-body imaging with background body signal suppression/T2-weighted image fusion of gastrointestinal cancers. Mol Clin Oncol 2016;5:44-8. [PMID: 27330763 DOI: 10.3892/mco.2016.897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
212 Zhao S, Shao L, Wang Y, Meng Q, Yu J. Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and attenuation of PI3K/Akt/mTOR. Arch Med Sci 2020;16:1140-9. [PMID: 32864003 DOI: 10.5114/aoms.2019.85146] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Harrington C, Smith L, Bisland J, López González E, Jamieson N, Paterson S, Stanley AJ. Mediastinal node staging by positron emission tomography-computed tomography and selective endoscopic ultrasound with fine needle aspiration for patients with upper gastrointestinal cancer: Results from a regional centre. World J Gastrointest Endosc 2018; 10(1): 37-44 [PMID: 29375740 DOI: 10.4253/wjge.v10.i1.37] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
214 Hölscher AH, Fetzner UK. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction]. Chirurg 2012;83:702-8, 710-1. [PMID: 22878576 DOI: 10.1007/s00104-011-2264-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
215 Wan JJ, Fei SJ, Lv SX, Han ST, Ma XG, Xu DS, Chen HM, Zhang J. Role of gastroscopic biopsy of gastric ulcer margins and healed sites in the diagnosis of early gastric cancer: A clinical controlled study of 513 cases. Oncol Lett 2018;16:4211-8. [PMID: 30250534 DOI: 10.3892/ol.2018.9156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Kwon Y, Kwon JW, Ha J, Kim D, Cho J, Jeon SM, Park SH, Hwang J, Kim NH, Park S. Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score. Gastric Cancer 2021. [PMID: 34296379 DOI: 10.1007/s10120-021-01216-2] [Reference Citation Analysis]
217 Findlay M, Purvis M, Venman R, Luong R, Carey S. Nutritional management of patients with oesophageal cancer throughout the treatment trajectory: benchmarking against best practice. Support Care Cancer 2020;28:5963-71. [PMID: 32281035 DOI: 10.1007/s00520-020-05416-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Tozzo P, Caenazzo L, Rodriguez D, Bolcato M. Delayed diagnosis of Wernicke encephalopathy with irreversible neural damage after subtotal gastrectomy for gastric cancer: A case of medical liability? Int J Surg Case Rep 2017;30:76-80. [PMID: 27988455 DOI: 10.1016/j.ijscr.2016.11.058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
219 Powell AGMT, Chin C, Coxon AH, Chalishazar A, Christian A, Roberts SA, Lewis WG. Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma. BJS Open 2020;4:416-23. [PMID: 32232963 DOI: 10.1002/bjs5.50277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
220 Kamarajah SK, Markar SR, Phillips AW, Salti GI, Dahdaleh FS. Local Endoscopic Resection is Inferior to Gastrectomy for Early Clinical Stage T1a and T1b Gastric Adenocarcinoma: A Propensity-Matched Study. Ann Surg Oncol 2021;28:2992-8. [PMID: 33452601 DOI: 10.1245/s10434-020-09485-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Powell AG, Wheat JR, Eley C, Robinson D, Roberts SA, Lewis W. Economic cost–utility analysis of stage-directed gastric cancer treatment. BJS Open 2021;5:zrab129. [DOI: 10.1093/bjsopen/zrab129] [Reference Citation Analysis]
222 Noble F, Mellows T, McCormick Matthews LH, Bateman AC, Harris S, Underwood TJ, Byrne JP, Bailey IS, Sharland DM, Kelly JJ, Primrose JN, Sahota SS, Bateman AR, Thomas GJ, Ottensmeier CH. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. Cancer Immunol Immunother 2016;65:651-62. [PMID: 27020682 DOI: 10.1007/s00262-016-1826-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 9.8] [Reference Citation Analysis]
223 Allen DC. Oesophageal Carcinoma. Histopathology Reporting. London: Springer; 2013. pp. 3-13. [DOI: 10.1007/978-1-4471-5263-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
224 Cai JQ, Xu XW, Mou YP, Chen K, Pan Y, Wu D. Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics. Tumour Biol. 2016;37:1641-1650. [PMID: 26307396 DOI: 10.1007/s13277-015-3948-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
225 Chen S, Feng Y, Zhang B, Chen X, Wei W, Ma H. RMP promotes the proliferation and radioresistance of esophageal carcinoma. J Cancer 2019;10:3698-705. [PMID: 31333787 DOI: 10.7150/jca.32680] [Reference Citation Analysis]
226 Chong CS, Ng CW, Shabbir A, Kono K, So JBY. Computed tomography of the thorax for gastric cancer staging: is it necessary? Scand J Surg 2015;104:244-7. [DOI: 10.1177/1457496915571400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
227 Bencivenga M, Torroni L, Verlato G, Mengardo V, Sacco M, Allum WH, de Manzoni G. Lymphadenectomy for gastric cancer at European specialist centres. Eur J Surg Oncol 2021;47:1048-54. [PMID: 33092970 DOI: 10.1016/j.ejso.2020.10.013] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
228 Messager M, Neofytou K, Chaudry MA, Allum WH. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients. Eur J Surg Oncol 2015;41:1316-23. [PMID: 26166786 DOI: 10.1016/j.ejso.2015.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
229 Lin DC, Wang MR, Koeffler HP. Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients. Gastroenterology. 2018;154:374-389. [PMID: 28757263 DOI: 10.1053/j.gastro.2017.06.066] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 18.0] [Reference Citation Analysis]
230 Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016; 22(10): 2875-2893 [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
231 Sisic L, Strowitzki MJ, Blank S, Nienhueser H, Dorr S, Haag GM, Jäger D, Ott K, Büchler MW, Ulrich A, Schmidt T. Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis. Gastric Cancer 2018;21:552-68. [DOI: 10.1007/s10120-017-0751-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
232 Brindle WM, Grant RK, Smith M, Suddaby M, Wallace A, Gillespie S, Church NI, Noble CL, Penman ID, Plevris JN, Robertson AR, Watson EF, Selinger CP, Kalla R, Masterton GSM. Risk stratifying gastric ulcers: development and validation of a scoring system. Frontline Gastroenterol 2022;13:111-8. [DOI: 10.1136/flgastro-2020-101759] [Reference Citation Analysis]
233 Gottlieb-vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J. Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis. Annals of Surgery 2019;270:1005-17. [DOI: 10.1097/sla.0000000000003252] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
234 Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO)., European Society of Surgical Oncology (ESSO)., European Society of Radiotherapy and Oncology (ESTRO). Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi57-63. [PMID: 24078663 DOI: 10.1093/annonc/mdt344] [Cited by in Crossref: 179] [Cited by in F6Publishing: 177] [Article Influence: 22.4] [Reference Citation Analysis]
235 Shang L, Hao JJ, Zhao XK, He JZ, Shi ZZ, Liu HJ, Wu LF, Jiang YY, Shi F, Yang H, Zhang Y, Liu YZ, Zhang TT, Xu X, Cai Y, Jia XM, Li M, Zhan QM, Li EM, Wang LD, Wei WQ, Wang MR. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction. Oncotarget. 2016;7:24374-24382. [PMID: 27016410 DOI: 10.18632/oncotarget.8223] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
236 Kanesaka T, Uedo N, Yao K, Ezoe Y, Doyama H, Oda I, Kaneko K, Kawahara Y, Yokoi C, Sugiura Y, Ishikawa H, Takeuchi Y, Arao M, Iwatsubo T, Iwagami H, Matsuno K, Muto M, Saito Y, Tomita Y. Multiple convex demarcation line for prediction of benign depressed gastric lesions in magnifying narrow-band imaging. Endosc Int Open 2018;6:E145-55. [PMID: 29399611 DOI: 10.1055/s-0043-121267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
237 Burbidge S, Mahady K, Naik K. The role of CT and staging laparoscopy in the staging of gastric cancer. Clin Radiol 2013;68:251-5. [PMID: 22985749 DOI: 10.1016/j.crad.2012.07.015] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
238 Schandl A, Johar A, Lagergren J, Lagergren P. Lymphadenectomy and health-related quality of life after oesophageal cancer surgery: a nationwide, population-based cohort study. BMJ Open 2016;6:e012624. [PMID: 27566643 DOI: 10.1136/bmjopen-2016-012624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
239 Huang L, Zhang X, Wei Z, Xu A. Importance of Examined Lymph Node Number in Accurate Staging and Enhanced Survival in Resected Gastric Adenocarcinoma-The More, the Better? A Cohort Study of 8,696 Cases From the US and China, 2010-2016. Front Oncol 2020;10:539030. [PMID: 33585181 DOI: 10.3389/fonc.2020.539030] [Reference Citation Analysis]
240 Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi K, Gu Y, Fang G. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability. FEBS J. 2014;281:802-813. [PMID: 24397586 DOI: 10.1111/febs.12625] [Cited by in Crossref: 148] [Cited by in F6Publishing: 151] [Article Influence: 18.5] [Reference Citation Analysis]
241 Chen C, Ma Z, Shang X, Duan X, Yue J, Jiang H. Risk factors for lymph node metastasis of the left recurrent laryngeal nerve in patients with esophageal squamous cell carcinoma. Ann Transl Med 2021;9:476. [PMID: 33850873 DOI: 10.21037/atm-21-377] [Reference Citation Analysis]
242 Lang B, Zhao S. miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2. Oncol Rep 2018;39:71-80. [PMID: 29115564 DOI: 10.3892/or.2017.6064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
243 Al-Momani H, Barnes R, El-Hadi A, Shah R, Lewis WG, Edwards P. Human epidermal growth factor receptor-2 in oesophageal cancers: An observational study. World J Gastroenterol 2012; 18(44): 6447-6451 [PMID: 23197890 DOI: 10.3748/wjg.v18.i44.6447] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
244 Rupasinghe SN, Stephens N. Oligometastasis to the testes from oesophageal adenocarcinoma. BMJ Case Rep 2022;15:e247684. [PMID: 35232740 DOI: 10.1136/bcr-2021-247684] [Reference Citation Analysis]
245 Halliday LJ, Doganay E, Wynter-Blyth VA, Hanna GB, Moorthy K. The Impact of Prehabilitation on Post-operative Outcomes in Oesophageal Cancer Surgery: a Propensity Score Matched Comparison. J Gastrointest Surg 2020. [PMID: 33269459 DOI: 10.1007/s11605-020-04881-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
246 Tandon A, Rajendran I, Aziz M, Kolamunnage-Dona R, Nunes QM, Shrotri M. Laparoscopy-assisted gastrectomy in the elderly: experience from a UK centre. Ann R Coll Surg Engl 2017;99:325-31. [PMID: 27869493 DOI: 10.1308/rcsann.2016.0344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
247 Old OJ, Isabelle M, Barr H. Staging Early Esophageal Cancer. Adv Exp Med Biol 2016;908:161-81. [PMID: 27573772 DOI: 10.1007/978-3-319-41388-4_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
248 Qu J, Ma L, Lu Y, Wang Z, Guo J, Zhang H, Yan X, Liu H, Kamel IR, Qin J, Li H. DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00464-7] [Reference Citation Analysis]
249 van Putten M, de Vos-Geelen J, Nieuwenhuijzen GAP, Siersema PD, Lemmens VEPP, Rosman C, van der Sangen MJC, Verhoeven RHA. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer. 2018;94:138-147. [PMID: 29571082 DOI: 10.1016/j.ejca.2018.02.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
250 Chidambaram S, Markar SR. Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2021:doab046. [PMID: 34286823 DOI: 10.1093/dote/doab046] [Reference Citation Analysis]
251 Lin S, Chen Y, Wang J, Cai Y, Chen X, Chen Y, Shi Y, Chen G, Zhu K. Multi-Region Genomic Landscape Analysis for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Carcinoma. Front Genet 2022;13:830601. [DOI: 10.3389/fgene.2022.830601] [Reference Citation Analysis]
252 Findlay JM, Gillies RS, Franklin JM, Teoh EJ, Jones GE, di Carlo S, Gleeson FV, Maynard ND, Bradley KM, Middleton MR. Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery. Eur Radiol 2016;26:3519-33. [PMID: 26883329 DOI: 10.1007/s00330-016-4227-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
253 Er P, Qian D, Zhang W, Zhang B, Wei H, Zhang T, Chen X, Wang Y, Zhao J, Wang Q, Pang Q, Wang P. The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy. Aging (Albany NY) 2020;12:6586-99. [PMID: 32330901 DOI: 10.18632/aging.102993] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 McAnena P, Neary C, Doyle C, Kerin MJ, McAnena OJ, Collins C. Serial CRP levels following oesophagectomy: a marker for anastomotic dehiscence. Ir J Med Sci 2020;189:277-82. [PMID: 31372815 DOI: 10.1007/s11845-019-02072-x] [Reference Citation Analysis]
255 Messager M, Pasquer A, Duhamel A, Caranhac G, Piessen G, Mariette C; FREGAT working groupFRENCH. Laparoscopic Gastric Mobilization Reduces Postoperative Mortality After Esophageal Cancer Surgery: A French Nationwide Study. Ann Surg 2015;262:817-22; discussion 822-3. [PMID: 26583671 DOI: 10.1097/SLA.0000000000001470] [Cited by in Crossref: 49] [Cited by in F6Publishing: 24] [Article Influence: 8.2] [Reference Citation Analysis]
256 Morgagni P, La Barba G, Colciago E, Vittimberga G, Ercolani G. Resection line involvement after gastric cancer treatment: handle with care. Updates Surg 2018;70:213-23. [DOI: 10.1007/s13304-018-0552-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Yarema R, de Manzoni G, Fetsych T, Ohorchak M, Pliatsko M, Bencivenga M. On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer. World J Gastrointest Oncol 2016; 8(6): 489-497 [PMID: 27326318 DOI: 10.4251/wjgo.v8.i6.489] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
258 Glen P. The role of stents in the palliation of oesophageal cancer. BMJ Support Palliat Care 2016;6:135-9. [DOI: 10.1136/bmjspcare-2014-000802] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
259 Lui SA, Tan WB, Tai BC, Yong WP, Mu YS, Ti TK, Shabbir A, So J. Predictors of survival outcome following radical gastrectomy for gastric cancer. ANZ J Surg 2019;89:84-9. [PMID: 30690932 DOI: 10.1111/ans.15011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
260 Hynes O, Anandavadivelan P, Gossage J, Johar A, Lagergren J, Lagergren P. The impact of pre- and post-operative weight loss and body mass index on prognosis in patients with oesophageal cancer. European Journal of Surgical Oncology (EJSO) 2017;43:1559-65. [DOI: 10.1016/j.ejso.2017.05.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
261 Hölscher AH, Babic B. New approaches in esophageal carcinomas. Innov Surg Sci 2016;1:87-95. [PMID: 31579724 DOI: 10.1515/iss-2016-0020] [Reference Citation Analysis]
262 Findlay JM, Dickson E, Fiorani C, Bradley KM, Mukherjee S, Gillies RS, Maynard ND, Middleton MR. Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence. Eur Radiol 2019;29:6717-27. [PMID: 31278574 DOI: 10.1007/s00330-019-06310-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
263 Hayee B, Inoue H, Sato H, Santi EG, Yoshida A, Onimaru M, Ikeda H, Kudo SE. Magnification narrow-band imaging for the diagnosis of early gastric cancer: a review of the Japanese literature for the Western endoscopist. Gastrointest Endosc. 2013;78:452-461. [PMID: 23632326 DOI: 10.1016/j.gie.2013.03.1333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
264 Phillips AW, Hardy K, Navidi M, Kamarajah SK, Madhavan A, Immanuel A, Griffin SM. Impact of Lymphadenectomy on Survival After Unimodality Transthoracic Esophagectomy for Adenocarcinoma of Esophagus. Ann Surg Oncol 2020;27:692-700. [DOI: 10.1245/s10434-019-07905-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
265 Messager M, de Steur W, Boelens P, Jensen L, Mariette C, Reynolds J, Osorio J, Pera M, Johansson J, Kołodziejczyk P, Roviello F, De Manzoni G, Mönig S, Allum W. Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group – European Registration of Cancer Care). European Journal of Surgical Oncology (EJSO) 2016;42:1432-47. [DOI: 10.1016/j.ejso.2016.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
266 Wu H, Zhuang W, Huang S, Guan X, Zheng Y, Xie Z, Chen G, Tang J, Zhou H, Xie L, Ben X, Zhou Z, Li Z, Chen R, Qiao G. Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:619556. [PMID: 34113556 DOI: 10.3389/fonc.2021.619556] [Reference Citation Analysis]
267 Groene O, Chadwick G, Riley S, Hardwick RH, Crosby T, Greenaway K, Allum W, Cromwell DA. Re-organisation of oesophago-gastric cancer services in England and Wales: a follow-up assessment of progress and remaining challenges. BMC Res Notes 2014;7:24. [PMID: 24406032 DOI: 10.1186/1756-0500-7-24] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
268 Machairas N, Charalampoudis P, Molmenti EP, Kykalos S, Tsaparas P, Stamopoulos P, Sotiropoulos GC. The value of staging laparoscopy in gastric cancer. Ann Gastroenterol 2017;30:287-94. [PMID: 28469358 DOI: 10.20524/aog.2017.0133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
269 Patrão AS, Papaxoinis G, Kordatou Z, Weaver JM, Owen-holt V, Alkhaffaf B, Galloway S, Mansoor W. Prognostic significance of positive circumferential resection margin post neoadjuvant chemotherapy in patients with esophageal or gastro-esophageal junction adenocarcinoma. European Journal of Surgical Oncology 2019;45:439-45. [DOI: 10.1016/j.ejso.2018.10.530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
270 Weledji EP. The principles of the surgical management of gastric cancer. Int J Surg Oncol (N Y) 2017;2:e11. [PMID: 29177225 DOI: 10.1097/IJ9.0000000000000011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
271 Rod X, Fuks D, Macovei R, Levard H, Ferraz J, Denet C, Tubbax C, Gayet B, Perniceni T. Comparison between open and laparoscopic gastrectomy for gastric cancer: A monocentric retrospective study from a western country. Journal of Visceral Surgery 2018;155:91-7. [DOI: 10.1016/j.jviscsurg.2017.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
272 Jones CM, Lyles A, Foley KG. A national cross-sectional survey investigating the use of endoscopic ultrasound in the diagnosis and treatment of oesophageal cancer in the UK. Clin Radiol 2021;76:458-64. [PMID: 33752881 DOI: 10.1016/j.crad.2021.02.021] [Reference Citation Analysis]
273 Foley KG, Pearson B, Riddell Z, Taylor SA. Opportunities in cancer imaging: a review of oesophageal, gastric and colorectal malignancies. Clin Radiol 2021;76:748-62. [PMID: 33579518 DOI: 10.1016/j.crad.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Lagergren J, Mattsson F, Davies A, Lindblad M, Lagergren P. Lymphadenectomy and risk of reoperation or mortality shortly after surgery for oesophageal cancer. Sci Rep 2016;6:36092. [PMID: 27796333 DOI: 10.1038/srep36092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
275 Babic B, Fuchs HF, Bruns CJ. [Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?]. Chirurg 2020;91:379-83. [PMID: 32140748 DOI: 10.1007/s00104-020-01150-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
276 Iwasaki H, Mizushima T, Suzuki Y, Fukusada S, Kachi K, Ozeki T, Anbe K, Tsukamoto H, Okumura F, Joh T, Sano H. Factors That Affect Stent-Related Complications in Patients with Malignant Obstruction of the Esophagus or Gastric Cardia. Gut Liver 2017;11:47-54. [PMID: 27728966 DOI: 10.5009/gnl16172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
277 Choi JH, Kim ES, Lee YJ, Cho KB, Park KS, Jang BK, Chung WJ, Hwang JS, Ryu SW. Comparison of quality of life and worry of cancer recurrence between endoscopic and surgical treatment for early gastric cancer. Gastrointest Endosc. 2015;82:299-307. [PMID: 25892060 DOI: 10.1016/j.gie.2015.01.019] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 9.4] [Reference Citation Analysis]
278 Lorenzen S, Biederstädt A, Ronellenfitsch U, Reißfelder C, Mönig S, Wenz F, Pauligk C, Walker M, Al-Batran SE, Haller B, Hofheinz RD. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV. BMC Cancer 2020;20:886. [PMID: 32933498 DOI: 10.1186/s12885-020-07388-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
279 Wang CP, Rogers MP, Bach G, Sujka J, Mhaskar R, DuCoin C. Safety comparison of minimally invasive abdomen-only esophagectomy versus minimally invasive Ivor Lewis esophagectomy: a retrospective cohort study. Surg Endosc 2021. [PMID: 33825009 DOI: 10.1007/s00464-021-08468-0] [Reference Citation Analysis]
280 Lutz MP, Zalcberg JR, Ducreux M, Ajani JA, Allum W, Aust D, Bang YJ, Cascinu S, Hölscher A, Jankowski J. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer. Eur J Cancer. 2012;48:2941-2953. [PMID: 22921186 DOI: 10.1016/j.ejca.2012.07.029] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 8.4] [Reference Citation Analysis]
281 Horiuchi Y, Fujisaki J, Yamamoto N, Ishizuka N, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T. Undifferentiated-type predominant mixed-type early gastric cancer is a significant risk factor for requiring additional surgeries after endoscopic submucosal dissection. Sci Rep 2020;10:6748. [PMID: 32317768 DOI: 10.1038/s41598-020-63781-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
282 Moehler M, Baltin CTH, Ebert M, Fischbach W, Gockel I, Grenacher L, Hölscher AH, Lordick F, Malfertheiner P, Messmann H, Meyer H, Palmqvist A, Röcken C, Schuhmacher C, Stahl M, Stuschke M, Vieth M, Wittekind C, Wagner D, Mönig SP. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer 2015;18:550-63. [DOI: 10.1007/s10120-014-0403-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
283 Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, Lee JI, Shin DB, Ji J, Chen JS, Lim Y, Ha S, Bang YJ; CLASSIC trial investigators. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15:1389-1396. [PMID: 25439693 DOI: 10.1016/s1470-2045(14)70473-5] [Cited by in Crossref: 451] [Cited by in F6Publishing: 277] [Article Influence: 56.4] [Reference Citation Analysis]
284 Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390:2383-2396. [PMID: 28648400 DOI: 10.1016/s0140-6736(17)31462-9] [Cited by in Crossref: 323] [Cited by in F6Publishing: 207] [Article Influence: 64.6] [Reference Citation Analysis]
285 Choi YY, Cheong JH, Noh SH. Advanced gastric cancer: is chemotherapy needed after surgery? Expert Rev Gastroenterol Hepatol. 2013;7:673-675. [PMID: 24161131 DOI: 10.1586/17474124.2013.841542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
286 Carder C, Fielding P, Roberts A, Foley K. Discordant nodal staging identifies intermediate-risk group for overall survival in patients with cT3 oesophageal adenocarcinoma. Eur Radiol 2020;30:3429-37. [PMID: 32055952 DOI: 10.1007/s00330-019-06642-6] [Reference Citation Analysis]
287 Martin L, de van der Schueren MAE, Blauwhoff-buskermolen S, Baracos V, Gramlich L. Identifying the Barriers and Enablers to Nutrition Care in Head and Neck and Esophageal Cancers: An International Qualitative Study. JPEN J Parenter Enteral Nutr 2015;40:355-66. [DOI: 10.1177/0148607114552847] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
288 Chidambaram S, Sounderajah V, Maynard N, Markar SR. Diagnostic Performance of Artificial Intelligence-Centred Systems in the Diagnosis and Postoperative Surveillance of Upper Gastrointestinal Malignancies Using Computed Tomography Imaging: A Systematic Review and Meta-Analysis of Diagnostic Accuracy. Ann Surg Oncol 2021. [PMID: 34762214 DOI: 10.1245/s10434-021-10882-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Noorani A, Bornschein J, Lynch AG, Secrier M, Achilleos A, Eldridge M, Bower L, Weaver JMJ, Crawte J, Ong CA, Shannon N, MacRae S, Grehan N, Nutzinger B, O'Donovan M, Hardwick R, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy. Genome Res 2017;27:902-12. [PMID: 28465312 DOI: 10.1101/gr.214296.116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
290 Piazzese C, Foley K, Whybra P, Hurt C, Crosby T, Spezi E. Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.PLoS One. 2019;14:e0225550. [PMID: 31756181 DOI: 10.1371/journal.pone.0225550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
291 Larsen AC, Holländer C, Duval L, Schønnemann K, Achiam M, Pfeiffer P, Yilmaz MK, Thorlacius-ussing O, Bæksgaard L, Ladekarl M. A Nationwide Retrospective Study of Perioperative Chemotherapy for Gastroesophageal Adenocarcinoma: Tolerability, Outcome, and Prognostic Factors. Ann Surg Oncol 2015;22:1540-7. [DOI: 10.1245/s10434-014-4127-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
292 Wang T, Chen VC, Yang Y, Chen C, Lee C, Wu S. The effects of anxiety on the receipt of treatments for esophageal cancer. Psycho-Oncology 2019;28:31-8. [DOI: 10.1002/pon.4903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
293 Phillips AW, Lagarde SM, Navidi M, Disep B, Griffin SM. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy. Annals of Surgery 2017;265:750-6. [DOI: 10.1097/sla.0000000000001737] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 6.4] [Reference Citation Analysis]
294 Cheng J, Wu J, Ye Y, Zhang C, Zhang Y, Wang Y. Extramural venous invasion detected by MDCT as an adverse imaging feature for predicting synchronous metastases in T4 gastric cancer. Acta Radiol 2017;58:387-93. [PMID: 27439402 DOI: 10.1177/0284185116658323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
295 Lv Y, Zhang Y, Li X, Ren X, Wang M, Tian S, Hou P, Shi B, Yang Q. Long telomere length predicts poor clinical outcome in esophageal cancer patients. Pathol Res Pract 2017;213:113-8. [PMID: 28027815 DOI: 10.1016/j.prp.2016.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
296 Gwynne S, Wijnhoven B, Hulshof M, Bateman A. Role of Chemoradiotherapy in Oesophageal Cancer — Adjuvant and Neoadjuvant Therapy. Clinical Oncology 2014;26:522-32. [DOI: 10.1016/j.clon.2014.05.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
297 Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37:375-382. [PMID: 23216458 DOI: 10.1111/apt.12177] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 8.1] [Reference Citation Analysis]
298 Findlay JM, Bradley KM, Maile EJ, Braden B, Maw J, Phillips-Hughes J, Gillies RS, Maynard ND, Middleton MR. Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy. Br J Surg 2015;102:1488-99. [PMID: 26458070 DOI: 10.1002/bjs.9905] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
299 Sonnenberg WR. Gastrointestinal Malignancies. Prim Care 2017;44:721-32. [PMID: 29132531 DOI: 10.1016/j.pop.2017.07.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Horiuchi Y, Fujisaki J, Yamamoto N, Ida S, Yoshimizu S, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Nagahama M, Takahashi H, Tsuchida T. Pretreatment diagnosis factors associated with overtreatment with surgery in patients with differentiated-type early gastric cancer. Sci Rep. 2019;9:15356. [PMID: 31653964 DOI: 10.1038/s41598-019-51952-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
301 Turkington RC, Parkes E, Kennedy RD, Eatock MM, Harrison C, McCloskey P, Purcell C. Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol. 2015;33:1088. [PMID: 25646194 DOI: 10.1200/JCO.2014.59.2402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
302 Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 2017;10:149. [PMID: 28810883 DOI: 10.1186/s13045-017-0517-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
303 Bencivenga M, Palla I, Scorsone L, Bortolami A, Mengardo V, Pavarana M, Turchetti G, de Manzoni G. Clinical pathways in gastric cancer care. Updates Surg 2018;70:279-91. [PMID: 29923079 DOI: 10.1007/s13304-018-0544-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
304 Powell AGMT, Wheat J, Patel N, Chan D, Foliaki A, Roberts SA, Lewis WG; South-East Wales Oesophagogastric Cancer Collaborative. Value of individual surgeon performance metrics as quality assurance measures in oesophagogastric cancer surgery. BJS Open 2020;4:91-100. [PMID: 32011808 DOI: 10.1002/bjs5.50230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
305 Park JS, Choe EA, Park S, Nam CM, Hyung WJ, Noh SH, Lee S, Kim HS, Jung M, Chung HC, Rha SY. Detection of asymptomatic recurrence improves survival of gastric cancer patients. Cancer Med 2021;10:3249-60. [PMID: 33932104 DOI: 10.1002/cam4.3899] [Reference Citation Analysis]
306 Bang YJ. Adjuvant chemotherapy: an option for Asian patients only? Recent Results Cancer Res 2012;196:291-305. [PMID: 23129381 DOI: 10.1007/978-3-642-31629-6_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
307 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891 [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
308 Yeo ST, Bray N, Haboubi H, Hoare Z, Edwards RT. Endoscopic ultrasound staging in patients with gastro-oesophageal cancers: a systematic review of economic evidence. BMC Cancer 2019;19:900. [PMID: 31500592 DOI: 10.1186/s12885-019-6116-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
309 Cowie A, Noble F, Underwood T. Strategies to improve outcomes in esophageal adenocarcinoma. Expert Rev Anticancer Ther 2014;14:677-87. [PMID: 24621143 DOI: 10.1586/14737140.2014.895668] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
310 Koëter M, van Steenbergen L, Lemmens V, Rutten H, Roukema J, Nieuwenhuijzen G. Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study. Cancer Epidemiology 2015;39:863-9. [DOI: 10.1016/j.canep.2015.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
311 Fountoulakis A, Souglakos J, Vini L, Douridas GN, Koumarianou A, Kountourakis P, Agalianos C, Alexandrou A, Dervenis C, Gourtsoyianni S, Gouvas N, Kalogeridi M, Levidou G, Liakakos T, Sgouros J, Sgouros SN, Triantopoulou C, Xynos E. Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer. Updates Surg 2019;71:599-624. [DOI: 10.1007/s13304-019-00696-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
312 Lastraioli E, Lottini T, Bencini L, Bernini M, Arcangeli A. hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers. Biomed Res Int 2015;2015:896432. [PMID: 26339650 DOI: 10.1155/2015/896432] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
313 Meister T, Heinzow HS, Osterkamp R, Wehrmann T, Kucharzik T, Domschke W, Domagk D, Seifert H. Miniprobe endoscopic ultrasound accurately stages esophageal cancer and guides therapeutic decisions in the era of neoadjuvant therapy: results of a multicenter cohort analysis. Surg Endosc. 2013;27:2813-2819. [PMID: 23404148 DOI: 10.1007/s00464-013-2817-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
314 Noble F, Curtis N, Harris S, Kelly JJ, Bailey IS, Byrne JP, Underwood TJ; South Coast Cancer Collaboration–Oesophago-Gastric (SC-OG). Risk assessment using a novel score to predict anastomotic leak and major complications after oesophageal resection. J Gastrointest Surg 2012;16:1083-95. [PMID: 22419007 DOI: 10.1007/s11605-012-1867-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
315 Whibley J, Peters CJ, Halliday LJ, Chaudry AM, Allum WH. Poor performance in incremental shuttle walk and cardiopulmonary exercise testing predicts poor overall survival for patients undergoing esophago-gastric resection. Eur J Surg Oncol 2018;44:594-9. [PMID: 29459017 DOI: 10.1016/j.ejso.2018.01.242] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
316 Blazeby JM, Strong S, Donovan JL, Wilson C, Hollingworth W, Crosby T, Nicklin J, Falk SJ, Barham CP, Hollowood AD, Streets CG, Titcomb D, Krysztopik R, Griffin SM, Brookes ST. Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer. Br J Cancer 2014;111:234-40. [PMID: 24921919 DOI: 10.1038/bjc.2014.313] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
317 Goense L, van der Sluis PC, van Rossum PSN, van der Horst S, Meijer GJ, Haj Mohammad N, van Vulpen M, Mook S, Ruurda JP, van Hillegersberg R. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival. J Surg Oncol 2017;115:812-20. [PMID: 28267212 DOI: 10.1002/jso.24596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
318 Liu X, Wang S, Xia X, Chen Y, Zhou Y, Wu X, Zhang J, He S, Tan Y, Qiang F, Røe OD, Li G, Zhou J. Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer. PLoS One 2012;7:e52348. [PMID: 23285001 DOI: 10.1371/journal.pone.0052348] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
319 Ma Y, Wei X, Han G, Xue M, Li G, Li Y. Glutathione S-transferase P1 Ile105Val polymorphism contributes to increased risk of gastric cancer in East Asians. Tumour Biol 2013;34:1737-42. [PMID: 23456768 DOI: 10.1007/s13277-013-0711-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
320 Sun K, Goodfellow H, Konstantara E, Hill A, Lennard D, Lloyd-Dehler E, Mughal M, Pritchard-Jones K, Robson C, Murray E. The multidisciplinary, theory-based co-design of a new digital health intervention supporting the care of oesophageal cancer patients. Digit Health 2021;7:20552076211038410. [PMID: 34873450 DOI: 10.1177/20552076211038410] [Reference Citation Analysis]
321 Lancellotta V, Cellini F, Fionda B, De Sanctis V, Vidali C, Fusco V, Barbera F, Gambacorta MA, Corvò R, Magrini SM, Tagliaferri L. The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival. Brachytherapy 2020;19:104-10. [PMID: 31636025 DOI: 10.1016/j.brachy.2019.09.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
322 Qureshi YA, Muntzer Mughal M, Fragkos KC, Lawrence D, George J, Mohammadi B, Dawas K, Booth H. Acquired Adult Aerodigestive Fistula: Classification and Management. J Gastrointest Surg 2018;22:1785-94. [PMID: 29943138 DOI: 10.1007/s11605-018-3811-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
323 Stavrou EP, Ward R, Pearson SA. Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data. BMC Health Serv Res 2012;12:384. [PMID: 23136982 DOI: 10.1186/1472-6963-12-384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
324 Fabbri C, Luigiano C, Lisotti A, Cennamo V, Virgilio C, Caletti G, Fusaroli P. Endoscopic ultrasound-guided treatments: Are we getting evidence based - a systematic review. World J Gastroenterol 2014; 20(26): 8424-8448 [PMID: 25024600 DOI: 10.3748/wjg.v20.i26.8424] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 55] [Article Influence: 9.3] [Reference Citation Analysis]
325 Zhu X, Bledsoe JR. Frozen section diagnosis of gastrointestinal poorly cohesive and signet-ring cell adenocarcinoma: useful morphologic features to avoid misdiagnosis. Virchows Arch 2020;477:497-506. [PMID: 32215719 DOI: 10.1007/s00428-020-02799-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 Yin K, Liu M, Zhang M, Wang F, Fen M, Liu Z, Yuan Y, Gao S, Yang L, Zhang W, Zhang J, Guo B, Xu J, Liang H, Chen X, Guan W. miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer. Oncotarget 2016;7:67321-32. [PMID: 27634902 DOI: 10.18632/oncotarget.12006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
327 Bringeland EA, Wasmuth HH, Grønbech JE. Perioperative chemotherapy for resectable gastric cancer – what is the evidence? Scandinavian Journal of Gastroenterology 2017;52:647-53. [DOI: 10.1080/00365521.2017.1293727] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
328 Bringeland EA, Wasmuth HH, Fougner R, Mjønes P, Grønbech JE. Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery. Br J Surg. 2014;101:1712-1720. [PMID: 25312592 DOI: 10.1002/bjs.9650] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
329 Keskin S, Yıldız I, Sen F, Aydogan F, Kilic L, Ekenel M, Saglam S, Sakar B, Disci R, Aykan F. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC). Clin Transl Oncol 2013;15:403-8. [PMID: 23054756 DOI: 10.1007/s12094-012-0942-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]